We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Smartphone Stethoscope Captures, Analyzes and Shares Cardiovascular and Pulmonary Sound Data

By HospiMedica International staff writers
Posted on 07 Jun 2023

As human longevity increases, the incidence of heart disease and cardiac complications related to other conditions also rises. More...

Currently, cardiovascular diseases (CVDs) are the primary cause of death worldwide, accounting for 32% of all global fatalities. Consequently, the population at risk of CVD is increasing, creating the need for convenient, accessible screening for symptoms whenever and wherever they occur. A pioneering technology now allows for the collection and sharing of medical-grade cardiac and pulmonary data using just a smartphone. This unique audio technology captures and utilizes the rich diagnostic potential concealed in chest sounds to take cardiac assessment beyond the clinic.

Sparrow BioAcoustics’ (Newfoundland, Canada) breakthrough software transforms smartphones into class-leading stethoscopes capable of capturing, analyzing, and sharing cardiovascular and pulmonary sound data. The Stethophone app, which can be downloaded onto smartphones, utilizes advanced acoustic processing to equip smartphones with highly sensitive cardiac and pulmonary listening capabilities. The uniqueness of Stethophone lies in its simplicity: there is no need for new plug-ins, charging, or connections. Heart and lung sounds can be recorded by merely placing a smartphone on a patient's chest, eliminating the need for additional devices.

A heartbeat's sound is produced by the opening and closing of heart valves and the circulation of blood. When valves malfunction, causing irregular or possibly reversed blood flow, the heart emits abnormal sounds. A wide range of defects and conditions can be identified through the analysis of the sounds emitted by a beating heart. While human hearing can detect sounds from 20 Hz to 20,000 Hz, heart sounds tend to be on the extremes of this range. Sparrow's Stethophone employs bioacoustic engineering to capture these sounds using a smartphone's built-in microphone. The app filters, isolates, compresses, and amplifies barely audible sounds, enabling it to extract almost imperceptible audio signals from a sea of vibrations. These signals carry a wealth of diagnostic information about the heart's structure and condition.

Sparrow’s Stethophone transforms a smartphone into a medical-grade stethoscope, offering enhanced audio, dynamic visualizations of recordings, advanced analysis, and secure transmission of examinations. Sparrow is the first company to develop and receive clearance for software that allows a smartphone to act as a scanner for cardiac signals, matching or surpassing the performance of current gold-standard clinical devices. In recent trials, 70% of medical professionals rated the Stethophone as having superior diagnostic sound performance compared to other leading devices. The Stethophone also outperformed in terms of overall correct heart pathology diagnosis and correct normal heart diagnosis.

“Our goal is to enable large-scale, rapid detection of cardiac and pulmonary symptoms, wherever they occur,” said Mark Attila Opauszky, CEO of Sparrow BioAcoustics. “There is a world of diagnostic information contained in chest sounds, and the healthcare system needs a practical way to capture this data and put it to work for the benefit of patients. Stethophone eliminates the main obstacles to doing that.”

Related Links:
Sparrow BioAcoustics 


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
High-Precision QA Tool
DEXA Phantom
New
Hospital Data Analytics App
Alarm History Analytics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.